Critical novel foods update: FSA Confirms that Valid CBD Novel Foods Applications Must Include Toxicology Safety Study Data
With just 6 months remaining, for CBD companies to have a valid novel foods application for each of their products, the ACI has received confirmation from the FSA that these dossiers must include toxicology safety study data and literature-based information is not sufficient.
[BusinessCann] ‘Big Pharma’ And ‘Black Market’ Fears In Wake Of Europe’s ‘Narcotic’ CBD Call
Any decisions concerning CBD in Europe would have little impact on the UK market, and could even be a golden opportunity for our domestic CBD industry, which is estimated to be worth £1bn by 2025.
ACI Announces “The Future of CBD in Grocery” Webinar in Partnership with The Grocer
The ACI will host their latest in a series of webinars on 22 September, in conjunction with the UK’s leading magazine for the FMCG industry, The Grocer and one of North America’s most established cannabis companies, Columbia Care.
[New Food] The Potential Impact of Classifying CBD as a Narcotic
The European Commission is reviewing whether CBD should be classified as a narcotic. Dr Parveen Bhatarah, Head of Regulatory and Compliance Unit at The Association of the Cannabinoid Industry, explains the impact this could have on both the European and UK markets.
[Food Navigator] Love Hemp: ‘We’ve positioned ourselves as a global brand’
The CBD industry has just been dealt a potentially dangerous blow, however, with the news that the European Commission is considering classifying it as a narcotic instead of a Novel Food. While a decision won’t be made before September, it could mean that hundreds of CBD and hemp products would be unable to legally retail on the European market.
[BusinessCann] Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers
Confirmation that the European Union is looking to treat CBD as a narcotic drug have rocked the industry.
BusinessCann reported earlier this month that moves were underway to change the status of cannabidiol (CBD) in the European Union from a food to a drug.
[Food Navigator] UK cannabinoid industry spots opportunity as EC considers reclassifying CBD a narcotic
The UK could be set to emerge as a global leader in the research and development of CBD as a food ingredient after the news that the European Commission has postponed the Novel Food applications of non-synthetic CBD products as it decides whether to class non-synthetic CBD as a narcotic.
The ACI to Partner with VOXPO for B2C and B2B CBD Event
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.
[Nutra Ingredients] CBD Novel Foods deadline fast approaching as firms embrace regulatory challenges
With UK FSA (Food Standards Agency) setting 31 March as the deadline for firms to have validated novel foods application for its #CBD products, how are firms responding to this challenge in the current climate?’
The ACI Partners with The ReLeaf CBD Podcast
The ACI is pleased to announce a partnership with The CBD Podcast by ReLeaf. The partnership commences with an interview with members of The ACI’s Regulatory and Compliance Unit, which is headed up by Dr Parveen Bhatarah. The team, which includes several new hires, ensures that our members are fully compliant with laws relating to cannabinoids.
